Tarsus Pharmaceuticals (TARS) Net Cash Flow (QoQ) (2020 - 2026)
Tarsus Pharmaceuticals (TARS) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Tarsus Pharmaceuticals |
2.71 Bn |
2.61 Bn |
152.66 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
-215.64% |
| Dec 31, 2025 |
341.13% |
| Sep 30, 2025 |
120.31% |
| Jun 30, 2025 |
-197.74% |
| Mar 31, 2025 |
202.71% |
| Dec 31, 2024 |
-1,513.69% |
| Sep 30, 2024 |
61.26% |
| Jun 30, 2024 |
59.64% |
| Mar 31, 2024 |
-1,711.13% |
| Dec 31, 2023 |
-101.44% |
| Sep 30, 2023 |
194.04% |
| Jun 30, 2023 |
820.04% |
| Mar 31, 2023 |
94.21% |
| Dec 31, 2022 |
-28.94% |
| Sep 30, 2022 |
-207.85% |
| Jun 30, 2022 |
1,812.81% |
| Mar 31, 2022 |
129.50% |
| Dec 31, 2021 |
-276.46% |
| Sep 30, 2021 |
-65.59% |
| Jun 30, 2021 |
271.85% |
